Polymorphs of N- (4-chloro-3-methyl-5-isoxazolyl)2-[2-me thyl-4,5-(methylenedioxy) phenylacetyl]thiophene-3-sulfonamide, sodium salt

Details for Australian Patent Application No. 2007225206 (hide)

Owner Encysive Pharmaceuticals, Inc.

Inventors Reichwein, John F.; Hansen, Tim

Agent Spruson & Ferguson

Pub. Number AU-B-2007225206

PCT Pub. Number WO2007/106467

Priority 60/781,861 13.03.06 US

Filing date 12 March 2007

Wipo publication date 20 September 2007

Acceptance publication date 5 August 2010

International Classifications

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/42 (2006.01) - Oxazoles

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

2 October 2008 PCT application entered the National Phase

  PCT publication WO2007/106467 Priority application(s): WO2007/106467

5 August 2010 Application Accepted

  Published as AU-B-2007225206

2 December 2010 Standard Patent Sealed

11 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007225207-Formulations of sitaxsentan sodium

2007225204-Package for holding multiple media discs and methods of making the same